Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-22-036232

Options or other derivatives

  • Chief Medical Officer acquired 625,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ferguson James J. III Chief Medical Officer 2022-12-20 Grant or award · Stock Option (right to Buy) +625,000 625,000 D
Loading xslF345X03/ownership.xml…